Lataa...
Nanoparticle and Iron Chelators as a Potential Novel Alzheimer Therapy
Current therapies for Alzheimer disease (AD) such as the acetylcholinesterase inhibitors and the latest NMDA receptor inhibitor, Namenda, provide moderate symptomatic delay at various stages of the disease, but do not arrest the disease progression or bring in meaningful remission. New approaches to...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2010
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2836834/ https://ncbi.nlm.nih.gov/pubmed/20013176 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/978-1-60327-029-8_8 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|